| Viral vectors: a look back and ahead on gene transfer technology L Vannucci, M Lai, F Chiuppesi, L Ceccherini-Nelli, M Pistello New Microbiologica 36 (1), 1-22, 2013 | 441 | 2013 |
| Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex F Wussow, F Chiuppesi, J Martinez, J Campo, E Johnson, C Flechsig, ... PLoS pathogens 10 (11), e1004524, 2014 | 147 | 2014 |
| Vaccine-derived neutralizing antibodies to the human cytomegalovirus gH/gL pentamer potently block primary cytotrophoblast infection F Chiuppesi, F Wussow, E Johnson, C Bian, M Zhuo, A Rajakumar, ... Journal of virology 89 (23), 11884-11898, 2015 | 98 | 2015 |
| Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission KM Bialas, T Tanaka, D Tran, V Varner, E Cisneros De La Rosa, ... Proceedings of the National Academy of Sciences 112 (44), 13645-13650, 2015 | 97 | 2015 |
| Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction M Campan, V Lionetti, GD Aquaro, F Forini, M Matteucci, L Vannucci, ... American Journal of Physiology-Heart and Circulatory Physiology 300 (6 …, 2011 | 95 | 2011 |
| MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults C La Rosa, J Longmate, J Martinez, Q Zhou, TI Kaltcheva, W Tsai, J Drake, ... Blood, The Journal of the American Society of Hematology 129 (1), 114-125, 2017 | 91 | 2017 |
| Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform F Chiuppesi, MA Salazar, H Contreras, VH Nguyen, J Martinez, Y Park, ... Nature communications 11 (1), 6121, 2020 | 88 | 2020 |
| Modeling human cytomegalovirus-induced microcephaly in human iPSC-derived brain organoids G Sun, F Chiuppesi, X Chen, C Wang, E Tian, J Nguyen, M Kha, D Trinh, ... Cell Reports Medicine 1 (1), 2020 | 79 | 2020 |
| Adaptive NK cell reconstitution is associated with better clinical outcomes F Cichocki, E Taras, F Chiuppesi, JE Wagner, BR Blazar, C Brunstein, ... JCI insight 4 (2), 2019 | 69 | 2019 |
| Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys CS Nelson, DV Cruz, D Tran, KM Bialas, L Stamper, H Wu, M Gilbert, ... JCI insight 2 (13), 2017 | 67 | 2017 |
| Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein M Celestino, A Calistri, C Del Vecchio, C Salata, F Chiuppesi, M Pistello, ... Journal of virology 86 (12), 6688-6700, 2012 | 48 | 2012 |
| A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection DJ Diamond, C La Rosa, F Chiuppesi, H Contreras, S Dadwal, F Wussow, ... Expert review of vaccines 17 (10), 889-911, 2018 | 45 | 2018 |
| Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates F Chiuppesi, VH Nguyen, Y Park, H Contreras, V Karpinski, K Faircloth, ... npj Vaccines 7 (1), 7, 2022 | 38 | 2022 |
| A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections F Chiuppesi, L Vannucci, A De Luca, M Lai, B Matteoli, G Freer, ... Journal of virology 86 (12), 6563-6574, 2012 | 38 | 2012 |
| Neutralization of human cytomegalovirus entry into fibroblasts and epithelial cells F Wussow, F Chiuppesi, H Contreras, DJ Diamond Vaccines 5 (4), 39, 2017 | 37 | 2017 |
| Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial F Chiuppesi, JA Zaia, PH Frankel, R Stan, J Drake, B Williams, AM Acosta, ... The Lancet Microbe 3 (4), e252-e264, 2022 | 36 | 2022 |
| Multiantigenic modified vaccinia virus ankara vaccine vectors to elicit potent humoral and cellular immune reponses against human cytomegalovirus in mice F Chiuppesi, J Nguyen, S Park, H Contreras, M Kha, Z Meng, T Kaltcheva, ... Journal of virology 92 (19), 10.1128/jvi. 01012-18, 2018 | 34 | 2018 |
| The AGMA1 poly (amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice M Donalisio, P Quaranta, F Chiuppesi, M Pistello, V Cagno, R Cavalli, ... Biomaterials 85, 40-53, 2016 | 32 | 2016 |
| Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivodendritic cells and T lymphocytes M Pistello, L Vannucci, A Ravani, F Bonci, F Chiuppesi, B Del Santo, ... Genetic vaccines and therapy 5, 1-13, 2007 | 27 | 2007 |
| Plasmablast response to primary rhesus cytomegalovirus (CMV) infection in a monkey model of congenital CMV transmission Q Fan, CS Nelson, KM Bialas, F Chiuppesi, J Amos, TC Gurley, ... Clinical and Vaccine Immunology 24 (5), e00510-16, 2017 | 16 | 2017 |
